Position in HLN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$42,413
+$822 QoQ
Shares Held
4,546
+9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#420
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Washington Trust Advisors, Inc. holds $173,445 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (24.5% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,413 | 4,546 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $41,591 | 4,155 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $42,006 | 4,155 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $37,269 | 4,155 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $43,833 | 4,227 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $42,671 | 4,147 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $39,561 | 4,147 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $40,753 | 3,852 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $31,478 | 3,811 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $29,068 | 3,424 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $24,360 | 2,960 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $24,656 | 2,960 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $5,472 | 653 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $15,295 | 1,879 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $15,032 | 1,879 | Shares | Other | 2023-02-08 | |
| 2022-09-30 | $9,293 | 1,526 | Shares | Other | 2022-10-14 | |
| No filing history on record for this holder in this stock. | ||||||